Literature DB >> 35353277

A Biophysical Study of Ru(II) Polypyridyl Complex, Properties and its Interaction with DNA.

Navaneetha Nambigari1,2, Aruna Kodipaka3, Ravi Kumar Vuradi4, Praveen Kumar Airva5, Satyanarayana Sirasani6.   

Abstract

Mononuclear Ru(II)Polypyridyl complexes of type [Ru(A)2BPIIP] (ClO4)2.2H2O, where BPIIP = 2-(3-(4-bromophenyl)isoxazole-5-yl)-1 H-imidazo [4,5-f] [1, 10] phenanthroline and A = bpy = bipyridyl (1), phen = 1,10 Phenanthroline (2), dmb = 4, 4' -dimethyl 2, 2'- bipyridine (3) & dmp = 4,4'-dimethyl-1,10 -Ortho Phenanthroline (4), were synthesized and their antibacterial activity were examined. The synthesized complexes were characterized and their interaction with DNA was studied using Computational and Biophysical methods (Absorption, emission methods, and viscosity). Molecular modelling studies were carried out for molecular geometry and electronic properties (Frontier molecular orbital HOMO-LUMO). The electrostatic potential surface contours for the complexes were analysed to give their nucleophilic level of sensitivity. The study reveals that the Ru(II) Polypyridyl complexes bind to DNA preponderantly by intercalation. The results recommend that the phen and dmp complex have more effective binding ability than the bpy and dmb, indicating the role of the ancillary ligand in determining their specificity for DNA binding. Further molecular docking studies suggested an octahedral geometry and bind to DNA by preferential binding to Guanine. The docking study additionally sustains the binding constant data acquired with the absorption and emission techniques.The results reveal that the nature of the ancillary Ligand plays a considerable role for the intercalation of the Ru(II) polypyridyl complex to DNA, which subsequently influences the antibacterial activity. Biological studies conducted on Gram-Negative (E.coli and K.pneumonia) and Gram-Positive (S. aureus and E. faecalis) bacteria establish that complex 1 and 2 were considerably active against S. aureus and E. coli.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Ancillary ligand; Antibacterial; Biophysical methods; DNA intercalation

Mesh:

Substances:

Year:  2022        PMID: 35353277     DOI: 10.1007/s10895-021-02879-x

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  30 in total

Review 1.  Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.

Authors:  Helen W Boucher; George H Talbot; John S Bradley; John E Edwards; David Gilbert; Louis B Rice; Michael Scheld; Brad Spellberg; John Bartlett
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

Review 2.  Anti-virulence strategies to combat bacteria-mediated disease.

Authors:  David A Rasko; Vanessa Sperandio
Journal:  Nat Rev Drug Discov       Date:  2010-01-18       Impact factor: 84.694

3.  Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE.

Authors:  Louis B Rice
Journal:  J Infect Dis       Date:  2008-04-15       Impact factor: 5.226

4.  Combating antimicrobial resistance: policy recommendations to save lives.

Authors:  Brad Spellberg; Martin Blaser; Robert J Guidos; Helen W Boucher; John S Bradley; Barry I Eisenstein; Dale Gerding; Ruth Lynfield; L Barth Reller; John Rex; David Schwartz; Edward Septimus; Fred C Tenover; David N Gilbert
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

Review 5.  Molecular mechanisms of antibiotic resistance.

Authors:  Jessica M A Blair; Mark A Webber; Alison J Baylay; David O Ogbolu; Laura J V Piddock
Journal:  Nat Rev Microbiol       Date:  2014-12-01       Impact factor: 60.633

Review 6.  Clinical relevance of the ESKAPE pathogens.

Authors:  Jack N Pendleton; Sean P Gorman; Brendan F Gilmore
Journal:  Expert Rev Anti Infect Ther       Date:  2013-03       Impact factor: 5.091

Review 7.  Metallodrugs in medicinal inorganic chemistry.

Authors:  Katja Dralle Mjos; Chris Orvig
Journal:  Chem Rev       Date:  2014-01-23       Impact factor: 60.622

Review 8.  Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?

Authors:  Sreekanth Thota; Daniel A Rodrigues; Debbie C Crans; Eliezer J Barreiro
Journal:  J Med Chem       Date:  2018-02-26       Impact factor: 7.446

9.  A ruthenium(II) polypyridyl complex for direct imaging of DNA structure in living cells.

Authors:  Martin R Gill; Jorge Garcia-Lara; Simon J Foster; Carl Smythe; Giuseppe Battaglia; Jim A Thomas
Journal:  Nat Chem       Date:  2009-10-18       Impact factor: 24.427

10.  Precision targeted ruthenium(ii) luminophores; highly effective probes for cell imaging by stimulated emission depletion (STED) microscopy.

Authors:  Aisling Byrne; Christopher S Burke; Tia E Keyes
Journal:  Chem Sci       Date:  2016-06-30       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.